Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
STOPMiP-2: IPTp-DP Implementation in Papua
NCT05294406Phase 4Completed
- Sponsor
- Liverpool School of Tropical Medicine
- Start
- Feb 2022
- Primary completion
- Dec 2023
- Modality
- Bivalent/Multivalent Binders, Nucleic Acid-Directed Small Molecules, Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of dihydroartemisinin + piperaquine in malaria, sponsored by Liverpool School of Tropical Medicine. Primary endpoints: Adherence in pregnant women at 10 months and Delivery effectiveness at 10 months. Started Feb 2022; status: completed.
02
Drugs
dihydroartemisinin + piperaquine
03
Conditions
malaria
Beyond the preview
Go deeper on NCT05294406.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05294406.